XBiotech Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
XBIT Nasdaq 2834 NA02

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for XBiotech Inc

Could The XBiotech Inc. (NASDAQ:XBIT) Ownership Structure Tell Us Something Useful? - May 24th, 2022 1:06 pm
XBiotech Announces French National Agency (ANSM) Approval and National Cancer Institute (INSA) funding to Support Phase I/II/III Clinical Study for Natrunix™ in Combination with Trifluridine/Tipiracil (TASKIN) for Treatment of Metastatic Colorectal Cancer - Apr 28th, 2022 1:00 pm
XBiotech (NASDAQ:XBIT) shareholders have endured a 48% loss from investing in the stock a year ago - Mar 15th, 2022 3:00 pm
XBiotech Inks Clinical Manufacturing Deal - Feb 2nd, 2022 2:00 pm
XBiotech Announces First Patient Enrolled in Phase I Clinical Trial for Novel Arthritis Therapy Natrunix-SQ - Jan 26th, 2022 2:50 pm
Moderna CEO talks Omicron booster shots, 2022 COVID-19 vaccine sales forecasts, global vaccination - Jan 10th, 2022 3:18 pm
New COVID-19 vaccine that covers Omicron ‘will be ready in March,’ Pfizer CEO says - Jan 10th, 2022 2:45 pm
Do Insiders Own Lots Of Shares In XBiotech Inc. (NASDAQ:XBIT)? - Dec 15th, 2021 3:37 pm
FDA Approves XBiotech’s IND in Rheumatology - Dec 13th, 2021 1:00 pm
XBiotech to Launch Novel Candidate Therapy for Stroke - Oct 28th, 2021 3:59 pm
XBiotech's (NASDAQ:XBIT) investors will be pleased with their fantastic 514% return over the last three years - Sep 14th, 2021 3:48 pm
Dr. Benjamin Musher to Chair Phase 1-2 Study Evaluating XBiotech’s Natrunix™ Anti-Cancer Therapy in Pancreatic Cancer - Sep 8th, 2021 1:00 pm
XBiotech Announces Addition of Dr. Mark Ziats, M.D. Ph.D. as Medical Director - Aug 30th, 2021 1:00 pm
XBiotech Announces Payment of Dividend to Holders of Common Stock - Jul 30th, 2021 3:03 pm
XBiotech Announces Dividend to Holders of Common Stock - Jul 6th, 2021 8:30 pm
XBiotech Announces Receipt of $75 Million from Sale of Antibody - Jun 30th, 2021 3:46 pm
Is XBiotech Inc. (XBIT) Going to Burn These Hedge Funds? - Jun 29th, 2021 12:04 pm
XBiotech Announces First Patient Enrolled in Clinical Trial Evaluating XB2001 for the Treatment of Pancreatic Cancer - Jun 23rd, 2021 12:30 pm
Shareholders May Not Be So Generous With XBiotech Inc.'s (NASDAQ:XBIT) CEO Compensation And Here's Why - Jun 16th, 2021 6:52 am